BioGenes
Berlin, Germany biogenes.de From their website, Nov 2026
- GLP
- ISO 9001
- CLIA
Work here? Claim this listing
About
BioGenes develops custom antibodies, immunoassays, and analytical services for pharmaceutical and biotech companies. It also offers HCP analytics, non-clinical immunization studies, and integrated preclinical in vivo services from its base in Berlin, Germany.
Services
Custom immunoassay development and production
Develops and produces custom immunoassays in sandwich or competitive formats for applications such as quality control, drug discovery, and diagnostics.
Custom monoclonal antibody development
Develops monoclonal antibodies by hybridoma technology, including screening, pair search, and antibody modification.
Custom polyclonal antibody development
Generates polyclonal antibodies in rabbits, mice, goats, or sheep and prepares capture and detector antibodies.
Anti-idiotypic antibody development
Develops anti-idiotypic antibodies as part of customized antibody projects.
Recombinant antibody services
Supports transition from hybridoma to recombinant antibody formats.
Antibody and hybridoma sequencing
Sequences antibody variable regions or full-length antibodies using Sanger sequencing and reports VH/VL consensus sequences.
HCP analytical services
Performs host cell protein coverage analysis using 2D PAGE, 2D Western Blot, 2D DIGE, immunoaffinity chromatography, and optional mass spectrometry.
Custom HCP ELISA development
Develops custom host cell protein ELISAs for monitoring HCP impurities.
8 more services
- Generic HCP ELISA kits
- High-risk HCP ELISA kits
- Pharmacokinetic assays
- Immunogenicity assays
- Non-clinical immunization studies
- Integrated preclinical in vivo studies
- ELISA production service
- BlueCap buffers
- What to send
- For external hybridoma sequencing: fresh cell pellets with 1x10^6 hybridoma cells, frozen, including one back-up vial, o
Capabilities
- Assays and studies
- Antibodies
- ELISA
- CHO
- PK/PD
- Immunogenicity
- Hybridoma
13 more
- E. coli expression
- In vivo
- Sandwich assay
- Competitive assay
- CLIA
- FIA
- 2D PAGE
- 2D Western Blot
- 2D DIGE
- Immunoaffinity chromatography
- Mass spectrometry
- PK assay
- Immunogenicity assay
- Scale and capacity
- Starting from 50 kits
- Up to biosafety level 2
- Therapeutic areas
- Biopharmaceuticals
- Vaccine development
- Drug development
Instruments and platforms
- Sanger sequencing
- 2D PAGE
- Horizontal flat-bed SDS-PAGE
- Western blot
- Mass spectrometry
Modalities and species
- Modalities
- Antibody
- Peptide
- Oligonucleotide
- Vaccine
- Species and models
- Rabbit
- Mouse
- Goat
- Sheep
- Rat
- CHO
6 more
- E. coli
- HEK
- Mouse models with intact immune systems
- Genetically modified mouse models
- Immunocompetent mouse models
- Immunodeficient mouse models
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
ISO 9001:2015Self-reported
CLIASelf-reported
Company
- Type
- CRO
- Founded
- 1992
- Team
- 70 dedicated specialists
Locations
- Based in
- Berlin, Germany
- Serves
- Worldwide, more than 40 countries
Contacts
- Sales
- sales@biogenes.de on their site
- General contact
- service@biogenes.de on their site